DrugInfoSys

Glibornuride

Drug #338

Glibornuride is oral hypoglycemic agent. Glibornuride is used to reduce the blood sugar level in the treatment of type 2 diabetes mellitus.

Primary Characteristics

It is of Synthetic origin and belongs to Sulphonylurea.

It belongs to Potassium Channel (ATP sensitive) antagonist pharmacological group on the basis of mechanism of action and also classified in Antidiabetic Agent, Sulfonylurea pharmacological group.

Molecular Weight: 366.5 · pKa: 4.7 · Solubility in Water: Insoluble · Solubility in Alcohol: Insoluble · Non-proprietary name: Glibornuride.

Molecular structure of Glibornuride

Pharmacokinetics

Absorption: Glibornuride has an oral bioavailability is 98%.

Distribution: Glibornuride has a volume of distribution is 18.6 litre. plasma protein binding is 94.5%.

Elimination: it is metabolised via extensive by liver, plasma half-life is 8.2 hr, renal excretion is 60-72%.

Advertisement

Indications

Glibornuride is primarily indicated in conditions like Type II diabetes mellitus.

Contraindications

Glibornuride is contraindicated in conditions like Renal diseases, Hepatic disease, Iddm, Diabetic coma.

Dosage

Glibornuride's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
12.5 – 15 mgEvery 24hPO
Paediatric Dosage (20kg)
0 – 0Not Recommended in this Age Group
Neonatal Dosage (3kg)
0 – 0Not recommended in this age group

Drug Interactions

Unknown7 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Glibornuride produces potentially life-threatening effects which include Hypoglycemia , Hypoglycemia, Hypoglycemia. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Glibornuride are Coma, Drowsiness, Drowsiness, Confusion , Hypoglycemia, Sweating , Restlessness , Sweating, Hunger , Trembling .

Glibornuride is known to cause more or less tolerable side effects which are usually transient. These include Confusion, Nausea, SweatingX.

Warnings / Precautions

Interference in Pathology

Glibornuride may interfere in the diagnosis of Altered liver euzyme value, No effects on blood levels.

Available Brands

None recorded.

Storage Conditions

Glibornuride should be stored .

Drug Classification

  1. 1.18.7.2Oral hypoglycemics